Patents - Global Data - Dimensions
N/A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Applicants
- ASCENDIS PHARMA BONE DISEASES AS
[NORA names: Ascendis Pharma; Private Research]
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 05 April 2018 (05.04.2018) WIP0 I PCT ~~~~~~~~~~~~~ 01110101onDV10 0III11010100111Dlmoino oimIE (10) International Publication Number WO 2018/060312 Al (51) International Patent Classification: A61K 38/29 (2006.01) A61K 47/34 (2017.01) A61K 9/00 (2006.01) (21) International Application Number: PCT/EP2017/074594 (22) International Filing Date: 28 September 2017 (28.09.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16191454.4 29 September 2016 (29.09.2016) EP 17155846.3 13 February 2017 (13.02.2017) EP (71) Applicant: ASCENDIS PHARMA BONE DISEASES A/ S [DK/DK]; Tuborg Boulevard 5, 2900 Hellerup (DK). (72) Inventors: SPROGOE, Kennett; Vengestien 7, 2840 Holte (DK). HOLTEN-ANDERSEN, Lars; Rodtjornevej 8, st., 2720 Vanlose (DK). KARPF, David Brian; 203 Sherland Ave., Mountain View, California 94043 (US). (74) Agent: BUCHEL, Edwin; Isenbruck Bosl Horschler LLP Patentanwalte, EASTSITE ONE, Seckenheimer LandstraBe 4, 68163 Mannheim (DE). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: with international search report (Art. 21(3)) with sequence listing part of description (Rule 5.2(a)) (54) Title: PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS 0 (57) : The present invention relates to a pharmaceutical composition comprising a PTH compound, wherein after subcutaneous \" administration the pharmacokinetic profile of the PTH compound exhibits a peak to trough ratio of less than 4 within one injection 0 interval.
Patent Family Records (36)
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, US-20240173385-A1
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, US-11857603-B2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2024, AU-2017336251-B2
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, US-20230218722-A1
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, US-11759504-B2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, SI-3518961-T1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, RS-64177-B1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, PL-3518961-T3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, LT-3518961-T
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES A SPROGE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, KR-20230170810-A
PTH compounds with low peak-to-trough ratios
아센디스 파마 본 디지즈 에이/에스 КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2023, KR-102611820-B1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, HU-E062009-T2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, HR-P20230383-T1
PTH compounds with low peak-to-valley ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, ES-2943720-T3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-4218795-A3
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-4218795-A2
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, EP-3518961-B1
PTH compounds with low peak to trough ratios
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2023, DK-3518961-T3
PTH compounds with low peak-to-valley ratio
Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2023, CN-117257922-A
PTH compounds with low peak-to-valley ratio
Ascendis Pharma Bone Diseases AS SPROGOEE KENNETT, L. Holden-Anderson, D.B. Kapf
2023, CN-109789188-B
PTH COMPOUNDS WITH LOW PEAK-TO-MINIMUM RATIOS
Astsendis Farma Boun Dizizis A/S SPROGEE Kennett, KHOLTEN-ANDERSEN LARS, KARPF DEVID BRAJAN
2022, RU-2766959-C2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS KENNETT SPROGOE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2022, JP-2022116302-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2020, US-20200360488-A1
PTG CONNECTIONS WITH LOW PEAK TO MINIMUM RATIO
Асцендис Фарма Боун Дизизис А/С КАРПФ, Дэвид Брайан, СПРОГЕЕ, Кеннетт, ХОЛЬТЕН-АНДЕРСЕН, Ларс, (...more)
2020, RU-2019112919-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, ZA-201901813-B
PTH Compounds with Low Peak-To-Trough Ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, US-20190282668-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, SG-11201901558V-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS.
ASCENDIS PHARMA BONE DISEASES AS KENNETT SPROGØE, LARS HOLTEN-ANDERSEN, DAVID BRIAN KARPF
2019, MX-2019003182-A
PTH COMPOUNDS WITH LOW RELATIONSHIP BETWEEN PEAK AND MINIMUM LEVEL
ASCENDIS PHARMA BONE DISEASES AS HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, KARPF DAVID BRIAN, (...more)
2019, MA-46345-A
PTH compound with low peak to trough ratio
ASCENDIS PHARMA BONE DISEASES A SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, KR-20190062497-A
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, EP-3518961-A1
PTH compound with low peak-to-valley ratio
Arsendis Drug Bone Disease Co Ltd SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, CN-109789188-A
pth compounds with low peak-to-valley ratios
ASCENDIS PHARMA BONE DISEASES AS DAVID BRIAN KARPF, KENNETT SPROGØE, LARS HOLTEN-ANDERSEN
2019, BR-112019005793-A2
PTH compounds with low peak-to-trough ratios
Ascendis Pharma Bone Diseases AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2019, AU-2017336251-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
ASCENDIS PHARMA BONE DISEASES AS SPROGØE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2018, WO-2018060312-A1
PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS
Ascendis Pharma Bone Diseases AS SPROGOE KENNETT, HOLTEN ANDERSEN LARS, HOLTEN-ANDERSEN LARS, (...more)
2018, CA-3037447-A1